Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Head & Neck 2Breast 1

Conditions

Breast Neoplasms 3Lymphoma 2Head and Neck Neoplasms 2Lymphoma, Non-Hodgkin 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 30Radiotherapy 24pembrolizumab 21Cetuximab 21Docetaxel 13Fluorouracil 12Radiotherapy, Intensity-Modulated 10Paclitaxel 9Radiation 8Nivolumab 7Everolimus 7Carboplatin 7Oxaliplatin 6Gemcitabine 5Surgical Procedures, Operative 4Radiosurgery 4Magnetic Resonance Spectroscopy 4Gefitinib 4Erlotinib Hydrochloride 4Amifostine 4Pemetrexed 3Filgrastim 3Capecitabine 3Bleomycin 3Biopsy 3zalutumumab 2spartalizumab 2pegfilgrastim 2niraparib 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Head and Neck Neoplasms × Biopsy, Fine-Needle × Clear all
NCT05010369 2025-06-26

DOLPHIN-VIVO

University of Exeter

Phase NA Terminated
14 enrolled
Head & NeckLymphoid

Head and Neck Neoplasms, Lymphoma

NCT01114256 2017-08-03

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

Stanford University

Terminated
83 enrolled
BreastHead & NeckLymphoid

Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡